• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Full-Body MRI Detects Cancers Missed by Standard Screenings

by Fred Pennic 05/30/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
 Full-Body MRI Detects Cancers Missed by Standard Screenings
Source Credit: Preunvo Whole-Body MRI

What You Should Know: 

– Prenuvo, a leader in whole-body MRI for proactive health screening, today announced compelling results from its Polaris study. The real-world study of over 1,000 asymptomatic individuals found that whole-body MRI scans can detect critical conditions, including early-stage cancers, that are often missed by current standard screening guidelines. 

– The findings have been peer-reviewed and accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting 2025.

Early Detection of Hidden Cancers: Key Polaris Study Findings

The Polaris study involved 1,011 asymptomatic adults who underwent preventive whole-body MRI scans. Significantly, 2.2% of these individuals were subsequently diagnosed with confirmed cancers. Many of these were types often missed by routine screening tests, such as kidney, bladder, and ovarian cancers, which are typically detected only after symptoms arise, making treatment less effective. The study highlighted that most cancers detected through this method were found at an early stage, when treatment is generally more effective.

“The Polaris findings are incredibly encouraging,” said Yosef Chodakiewitz, Medical Director of Primary Care Radiology at Prenuvo. “We’re detecting cancers that current protocols miss, and we’re doing it early when patients have the best chance at a positive outcome”.

Accuracy, Reassurance, and the Role of Complementary Screening

The Polaris study, conducted at a single clinic in Canada, also provided insights into the accuracy of whole-body MRI in a real-world clinical setting. The scans offered meaningful reassurance, with 99.8% of patients who had a clear scan remaining cancer-free for at least a year. In instances where biopsies were recommended based on MRI findings, approximately half of those cases were confirmed to be cancer or another mass requiring treatment, indicating that the technology is effective at identifying medically relevant conditions.

Prenuvo emphasizes that whole-body MRI is intended to complement, not replace, existing standard screening methods. For example, the study noted that the small number of cancers not detected—fewer than 0.2% of cases—were breast cancers. Prenuvo continues to recommend regular mammography for breast cancer screening.

“No single test is perfect, but when combined, whole-body MRI and traditional screenings can dramatically improve our ability to detect disease early,” Dr. Chodakiewitz continued.

Ongoing Research and Advancing Clinical Interpretation

The Polaris study is part of a larger ongoing effort. Prenuvo is currently one year into its Hercules study, a large observational trial following 100,000 individuals to better understand how whole-body MRI can improve early detection, long-term health outcomes, and access to care.

Researchers are also piloting new reporting systems to assist medical professionals in interpreting whole-body MRI results more clearly. These tools aim to identify findings that require immediate action versus those that warrant monitoring. Among these are ONCO-RADS (for assessing cancer risk) and a new Clinically Significant Diagnoses (CSD) system (for evaluating the clinical importance of other detected conditions). Follow-up research from the initial Polaris cohort is also underway to evaluate the findings across a broader and more diverse population.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Oncology

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |